GlassScriptPhysician profile
Elizabeth Perazza
NPI 1942230891
$2,909.66
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $76.11 · 2021: $156 · 2022: $1,240 · 2023: $187 · 2024: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $428 · Travel and Lodging: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.23 |
| Travel and Lodging | $386.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,454.63 | 2019-2023 | Flexiva |
| Neotract INC. | $474.15 | 2019 | |
| Procept Biorobotics Corporation | $386.60 | 2024 | Aquabeam System |
| Becton, Dickinson and Company | $147.48 | 2024 | Proxis Ureteral Access Sheath, Bard Inlay Optima Ureteral Stent With Hydroglide Guidewire |
| Medtronic, INC. | $130.68 | 2021 | |
| Olympus Latin America, INC. | $100.00 | 2022 | |
| Merck Sharp & Dohme LLC | $93.51 | 2024 | Keytruda |
| Canon Medical Systems USA, INC. | $76.11 | 2020 | |
| Stryker Corporation | $46.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Perazza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.